Last reviewed · How we verify
NCT01151592: ASSURED
Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
Phase 4 trial testing Iron Sucrose in Iron Deficiency Anemia. Withdrawn.
Quick facts
| Lead sponsor | American Regent, Inc. |
|---|---|
| Phase | Phase 4 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Sites | 1 location across United States |
Drugs / interventions tested
- Iron Sucrose — full drug profile →
Conditions studied
- Iron Deficiency Anemia — all drugs for Iron Deficiency Anemia →
Sponsor
American Regent, Inc. — full company profile →
Who can join
18 and older, any sex, with Iron Deficiency Anemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to assess the safety and tolerability of Venofer in patients with chronic kidney disease who cannot tolerate Ferumoxytol (Feraheme) or intravenous iron containing a dextran (INFed or Dexferrum).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01151592
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Iron Sucrose
Trials testing the same drug.
- NCT03933813 — Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients · Phase 1, PHASE2 · terminated
- NCT03106298 — Iron Deficiency and FGF23 Regulation in CKD and HF · completed
- NCT01114204 — A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia · Phase 3 · completed
- NCT01052779 — A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic · Phase 2 · completed
Other recruiting trials for Iron Deficiency Anemia
Currently open trials in the same condition.
- NCT07483645 — Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Ane · active not recruiting
- NCT06012760 — The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion · NA · recruiting
- NCT06742528 — Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients · NA · recruiting
- NCT05929729 — Iron Deficiency Anemia (IDA) and the Brain · Phase 4 · recruiting
- NCT05985070 — Evaluating the Effectiveness of Various Iron Salts in Oral Iron Therapy for Iron Deficiency and Anemia in Healthy Adults · NA · active not recruiting
Other American Regent, Inc. trials
Trials by the same sponsor.
- NCT05661682 — Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety · Phase 4 · withdrawn
- NCT04968379 — Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia · Phase 2 · withdrawn
- NCT04269707 — Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfa · Phase 3 · completed
- NCT03523117 — Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA · Phase 3 · completed
- NCT02826681 — Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia · Phase 2 · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01151592 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by American Regent, Inc.
- Last refreshed: 24 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01151592.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing